Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

NCT05111197 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer

Interventions

RADIATION: SRT
DRUG: Immunotherapy

Sponsor

Institut Cancerologie de l'Ouest